Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $34,997 - $42,656
155 New
155 $37,000
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $185,628 - $209,355
827 New
827 $187,000
Q2 2021

Jul 28, 2021

SELL
$233.58 - $259.14 $2.02 Million - $2.24 Million
-8,628 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $1.91 Million - $2.23 Million
8,628 New
8,628 $2.15 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Guardian Wealth Advisors, LLC Portfolio

Follow Guardian Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.